These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Seminal anti-Müllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism. Sinisi AA; Esposito D; Maione L; Quinto MC; Visconti D; De Bellis A; Bellastella A; Conzo G; Bellastella G Hum Reprod; 2008 May; 23(5):1029-34. PubMed ID: 18343809 [TBL] [Abstract][Full Text] [Related]
23. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age]. Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740 [TBL] [Abstract][Full Text] [Related]
24. The role of anti-Müllerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome. Qi X; Pang Y; Qiao J Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():82-7. PubMed ID: 26914398 [TBL] [Abstract][Full Text] [Related]
25. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization. Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964 [TBL] [Abstract][Full Text] [Related]
26. Serum anti-Müllerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation. Genro VK; Grynberg M; Scheffer JB; Roux I; Frydman R; Fanchin R Hum Reprod; 2011 Mar; 26(3):671-7. PubMed ID: 21177311 [TBL] [Abstract][Full Text] [Related]
27. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325 [TBL] [Abstract][Full Text] [Related]
28. Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity. Magri F; Schena L; Capelli V; Gaiti M; Zerbini F; Brambilla E; Rotondi M; De Amici M; Spinillo A; Nappi RE; Chiovato L Reprod Biol Endocrinol; 2015 Sep; 13(1):106. PubMed ID: 26391773 [TBL] [Abstract][Full Text] [Related]
29. Baseline inhibin B and anti-Mullerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty. Coutant R; Biette-Demeneix E; Bouvattier C; Bouhours-Nouet N; Gatelais F; Dufresne S; Rouleau S; Lahlou N J Clin Endocrinol Metab; 2010 Dec; 95(12):5225-32. PubMed ID: 20826577 [TBL] [Abstract][Full Text] [Related]
31. The Sertoli cell hormones inhibin-B and anti Müllerian hormone have different patterns of secretion in prepubertal cryptorchid boys. Cortes D; Clasen-Linde E; Hutson JM; Li R; Thorup J J Pediatr Surg; 2016 Mar; 51(3):475-80. PubMed ID: 26452703 [TBL] [Abstract][Full Text] [Related]
32. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome. Li J; Li R; Yu H; Zhao S; Yu Y; Qiao J Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139 [TBL] [Abstract][Full Text] [Related]
33. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). La Marca A; Sighinolfi G; Radi D; Argento C; Baraldi E; Artenisio AC; Stabile G; Volpe A Hum Reprod Update; 2010; 16(2):113-30. PubMed ID: 19793843 [TBL] [Abstract][Full Text] [Related]
34. Anti-Mullerian Hormone (AMH) Determinations in the Pediatric and Adolescent Endocrine Practice. Weintraub A; Eldar-Geva T Pediatr Endocrinol Rev; 2017 Jun; 14(4):364-370. PubMed ID: 28613046 [TBL] [Abstract][Full Text] [Related]
35. FSH inhibits AMH to support ovarian estradiol synthesis in infantile mice. Devillers MM; Petit F; Cluzet V; François CM; Giton F; Garrel G; Cohen-Tannoudji J; Guigon CJ J Endocrinol; 2019 Feb; 240(2):215-228. PubMed ID: 30403655 [TBL] [Abstract][Full Text] [Related]
36. Clinical relevance of combined FSH and AMH observations in infertile women. Gleicher N; Kim A; Kushnir V; Weghofer A; Shohat-Tal A; Lazzaroni E; Lee HJ; Barad DH J Clin Endocrinol Metab; 2013 May; 98(5):2136-45. PubMed ID: 23533225 [TBL] [Abstract][Full Text] [Related]
37. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. Laven JS; Mulders AG; Visser JA; Themmen AP; De Jong FH; Fauser BC J Clin Endocrinol Metab; 2004 Jan; 89(1):318-23. PubMed ID: 14715867 [TBL] [Abstract][Full Text] [Related]
38. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment. Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015 [TBL] [Abstract][Full Text] [Related]
39. Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function. Moolhuijsen LME; Visser JA J Clin Endocrinol Metab; 2020 Nov; 105(11):3361-73. PubMed ID: 32770239 [TBL] [Abstract][Full Text] [Related]
40. Safety of standardised treatments for haematologic malignancies as regards to testicular endocrine function in children and teenagers. Grinspon RP; Arozarena M; Prada S; Bargman G; Sanzone M; Morales Bazurto M; Gutiérrez M; Bedecarrás P; Kannemann A; Elena GO; Gottlieb S; Berenstein AJ; Ropelato MG; Bergadá I; Aversa LA; Rey RA Hum Reprod; 2019 Dec; 34(12):2480-2494. PubMed ID: 31768530 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]